Natera Inc (NTRA):医療機器:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C7862)
◆英語タイトル:Natera Inc (NTRA) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7862
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年10月
◆ページ数:58
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, genetic carrier screening and paternity testing. Its pre-implantation genetic testing includes translocation testing, aneuploidy screening, and single gene testing. Natera offers constellation, a cloud-based software product that allows laboratory customers to gain access through the cloud to the company’s algorithms and bioinformatics in order to validate and launch tests. The company also undertakes clinical trial of several genetic materials. Natera is headquartered in San Carlos, California, the US.

Natera Inc (NTRA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Natera Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Natera Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Natera Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Natera Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Natera Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Natera Inc, Medical Equipment, Deal Details 12
Venture Financing 12
Natera Raises USD55.5 Million in Venture Financing 12
Natera Raises US$54.6 Million In Venture Financing 14
Gene Security Network Secures US$20 Million In Series D Financing 16
Partnerships 17
Unilabs Enters into Licensing Agreement with Natera 17
QIAGEN Enters into Agreement with Natera 18
Natera Enters into Agreement with Imperial College London and University of Leicester 19
Natera Enters into Research Agreement with Aarhus University 20
Natera Enters into Agreement with LifeLabs for Non-Invasive Prenatal Test 21
Diagcor Enters Into Agreement With Natera To Market Panorama NIPT In Hong Kong 22
Natera And Laboratorio Dr. F Echevarne Analisis Enter Into Agreement To Distribute Panorama 23
ARUP Labs Enters Into Co-Marketing Agreement With Natura For Panorama 24
Quest Diagnostics Enters Into Agreement With Natera To Offer Panorama, Non-Invasive Prenatal Screening Test 25
Equity Offering 26
Natera Prices Public Offering of Shares for USD90 Million 26
Natera Raises USD180 Million in IPO 28
Natera Inc – Key Competitors 30
Natera Inc – Key Employees 31
Natera Inc – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 33
Strategy And Business Planning 33
Jan 10, 2017: Natera terminates NIPT distribution agreement with Bioreference Labs 33
Financial Announcements 34
Aug 08, 2018: Natera reports second quarter 2018 financial results 34
May 08, 2018: Natera Reports First Quarter 2018 Financial Results 36
Mar 13, 2018: Natera Announces Fourth Quarter And Fiscal Year 2017 Financial Results 38
Nov 08, 2017: Natera Reports Third Quarter 2017 Financial Results 40
Aug 08, 2017: Natera Reports Second Quarter 2017 Financial Results 42
May 09, 2017: Natera Reports First Quarter 2017 Financial Results 44
Mar 07, 2017: Natera Reports Fourth Quarter and Fiscal Year 2016 Financial Results 46
Corporate Communications 48
Jul 31, 2018: Natera appoints Roy Baynes to Board of Directors adding deep oncology experience 48
Apr 09, 2018: Natera Appoints Paul R. Billings, M.D., Ph.D., as Chief Medical Officer 49
May 04, 2017: Natera Announces the Appointment of Gail Marcus as Member of the Board of Directors 50
Feb 03, 2017: Natera Announces Appointment of Mike Brophy as New Chief Financial Officer 51
Product News 52
Apr 13, 2018: Natera to Present Successful Results at AACR from Bladder and Colon Cancer Studies 52
Aug 21, 2017: Natera Launches Signatera Personalized Circulating Tumor DNA Technology for Cancer Research 53
Apr 26, 2017: Study in Nature Shows Early Relapse Detection in Lung Cancer Using Natera’s Technology for ctDNA Analysis 54
Other Significant Developments 55
Jun 19, 2018: Natera and Institut Jules Bordet partner on breast cancer research 55
Sep 20, 2017: Natera Selected for Circulating Tumor DNA Study in Bladder Cancer 56
Mar 01, 2017: Natera Announces Launch of Evercord Cord Blood and Tissue Banking Service 57
Appendix 58
Methodology 58
About GlobalData 58
Contact Us 58
Disclaimer 58

List of Tables
Natera Inc, Medical Equipment, Key Facts, 2017 2
Natera Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Natera Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Natera Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Natera Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Natera Inc, Deals By Market, 2012 to YTD 2018 9
Natera Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Natera Raises USD55.5 Million in Venture Financing 12
Natera Raises US$54.6 Million In Venture Financing 14
Gene Security Network Secures US$20 Million In Series D Financing 16
Unilabs Enters into Licensing Agreement with Natera 17
QIAGEN Enters into Agreement with Natera 18
Natera Enters into Agreement with Imperial College London and University of Leicester 19
Natera Enters into Research Agreement with Aarhus University 20
Natera Enters into Agreement with LifeLabs for Non-Invasive Prenatal Test 21
Diagcor Enters Into Agreement With Natera To Market Panorama NIPT In Hong Kong 22
Natera And Laboratorio Dr. F Echevarne Analisis Enter Into Agreement To Distribute Panorama 23
ARUP Labs Enters Into Co-Marketing Agreement With Natura For Panorama 24
Quest Diagnostics Enters Into Agreement With Natera To Offer Panorama, Non-Invasive Prenatal Screening Test 25
Natera Prices Public Offering of Shares for USD90 Million 26
Natera Raises USD180 Million in IPO 28
Natera Inc, Key Competitors 30
Natera Inc, Key Employees 31
Natera Inc, Subsidiaries 32

List of Figures
Natera Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Natera Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Natera Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Natera Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Natera Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Natera Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Natera Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Natera Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Natera Inc (NTRA):医療機器:M&Aディール及び事業提携情報(Natera Inc (NTRA) - Medical Equipment - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆